Asia-Pacific, as home to 50 percent of the world’s new cancer cases each year and with deaths caused by cancer expected to increase by 36 percent by…

Regulatory harmonisation for medical devices between countries in Asia-Pacific has long been a challenging issue, predominantly due to the extreme…

Mervyn Lim, Vice President, ResMed Asia, shares the company’s journey through COVID-19 in the region, how the company is building on their…

Leonora Lim, DHL’s Asia-Pacific VP for Life Sciences and Healthcare, Customer Solutions & Innovation, dives into the industry’s challenges…

Writing in the April edition of DIA’s Global Forum magazine, Dhiraj Behl, Janine Jamieson, and Harikesh Kalonia highlight some of the regulatory…

As the most important pharma hub in its region, and one of the most important globally, many companies look to launch new products in Singapore first…

Dr Choong May Ling, Mimi, CEO of Singapore’s Health Sciences Authority (HSA), one of the leading regulatory bodies in the Asia-Pacific region,…

At USD 150 billion, Asia-Pacific is home to the world’s second largest medtech market and, with a CAGR of nine percent, certainly its most dynamic.…

MSD’s Ashish Pal describes how he led the Singapore, Malaysia, and Brunei cluster through a challenging 2020; the importance of leveraging learnings…

In an exclusive and wide-ranging interview, Harjit Gill outlines the work of pan-Asia-Pacific medtech association APACMed, how COVID-19 represents a…

The latest pharma news from the Asia-Pacific region, including upcoming IPOs for Prestige Biopharma and HH&L Acquisition; logistics challenges for…

Japanese medtech player Terumo’s APAC lead Probir Das outlines the company’s 100-year commitment to innovation, its aggressive globalisation…